Biomarkers of adult and developmental neurotoxicity

Toxicology and Applied Pharmacology

Volumn 206, Issue 2, 2005, Pages 255-260

  Slikker Jr , William ^a   Bowyer, John F ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Amphetamine; Biomarkers; Gene expression; Nervous system; Neurotoxicity

Indexed keywords

AMPHETAMINE; METHAMPHETAMINE;

ACCURACY; ANALYTIC METHOD; BEHAVIOR; CELL POPULATION; CONFERENCE PAPER; DEVELOPMENTAL DISORDER; DEVELOPMENTAL STAGE; DISEASE MARKER; DISEASE PREDISPOSITION; DNA MICROARRAY; GENE EXPRESSION; GENOMICS; HALLUCINATION; HUMAN; HYPERTHERMIA; MENTAL DISEASE; NERVE DEGENERATION; NEUROBIOLOGY; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NEUROTOXICITY; NONHUMAN; PANIC; PARANOIA; PATHOGENESIS; REPRODUCIBILITY; TREMOR;

AMPHETAMINE; BIOLOGICAL MARKERS; GENE EXPRESSION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; NEUROPEPTIDE Y; NEUROTOXICITY SYNDROMES;

EID: 20644436900     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2004.09.022     Document Type: Conference Paper

References (56)

1. ATSDR (Agency for Toxic Substances and Disease Registry) Nature and extent of lead exposure of children in the United States: a report to congress U.S. Department of Health and Human Services 1988 U.S. Public Health Service Atlanta, GA
2. S.F. Ali, J. Buelke-Sam, G.D. Newport, and W. Slikker Jr. Early neurobehavioral and neurochemical alterations in rats prenatally exposed to imipramine Neurotoxicology 7 2 1986 365 380
3. S.F. Ali, J. Buelke-Sam, and W. Slikker Jr. Prenatal reserpine exposure in rats decreases caudate nucleus dopamine receptor binding in female offspring Toxicol. Lett. 36 1986 67 72
4. W.K. Anger Worker exposures Z. Annau Neurobehavioral Toxicology 1986 Johns Hopkins Press Baltimore 331 347
5. Z. Annau, and C.U. Eccles Prenatal exposure Z. Annau Neurobehavioral Toxicology 1986 Johns Hopkins Press Baltimore 153 169
6. J.F. Bowyer Neuronal degeneration in the limbic system of weanling rats exposed to saline, hyperthermia or d-ampheta-mine Brain Res. 885 2000 166 171
7. J.F. Bowyer, and R.R. Holson Methamphetamine and amphetamine neurotoxicity: characteristics, interactions with body temperature and possible mechanisms L.W. Chang R.S. Dyer Handb. Neurotoxicol. vol. II 1995 Marcel Dekker, Inc. New York 845 870
8. J.F. Bowyer, and S.L. Peterson Neuronal degeneration in the forebrain produced by amphetamine, methamphetamine and fenfluramine D.S. Lester W. Slikker Jr. P. Lazarovici Site-selective Neurotoxicity 2002 Taylor and Francis New York, NY 207 232
9. J.F. Bowyer, D.L. Davies, L. Schmued, H.W. Broening, G.D. Newport, W. Slikker Jr., and R.R. Holson Further studies of the role of hyperthermia in methamphetamine neurotoxicity J. Pharmacol. Exp. Ther. 268 1994 1571 1580
10. J.F. Bowyer, S.I. Peterson, R.L. Rountree, J. Tor-Agbidye, and G.J. Wang Neuronal degeneration in rat forebrain resulting from d-amphetamine-induced convulsions is dependent on seizure severity and age Brain Res. 809 1998 77 99
11. J.F. Bowyer, A.J. Harris, R.R. Delongchamp, R.L. Jakab, D.A. Miller, R. Little, and J.P. O'Callaghan Selective changes in gene expression in cortical regions sensitive to amphetamine during the neurodegenerative process Neurotoxicology 25 2004 555 572
12. J.L. Cadet, S. Jayanthi, M.T. McCoy, M. Vawter, and B. Ladenheim Temporal profiling of methamphetamine-induced changes in gene expression in the mouse brain: evidence from cDNA array Synapse 41 2001 40 48
13. R.T. Cheung, and D.F. Cechetto Neuropeptide changes following excitotoxic lesion of the insular cortex in rats J. Comp. Neurol. 362 1995 535 550
14. D.R. Clemmons Insulin-like growth factor binding proteins and their role in controlling IGF actions Cytokine Growth Factor Rev. 8 1997 45 62
15. D.L. Commins, and L.S. Seiden a-Methyltyrosine blocks methylamphetamine-induced degeneration in the rat somatosensory cortex Brain Res. 365 1986 15 20
16. Committee on Biological Markers of the National Research Council Biological markers in environmental health research Environ. Health Perspect. 74 1987 3 9
17. C. Davidson, A.J. Gow, T.H. Lee, and E.H. Ellinwood Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment Brain Res. 36 2001 1 22
18. R.R. Delongchamp, A.J. Harris, and J.F. Bowyer A statistical approach in using cDNA array analysis to finding modest, 2-fold or less, changes in several brain regions after neurotoxic insult Ann. N. Y. Acad. Sci. 993 2003 363 376
19. R.R. Delongchamp, J.F. Bowyer, J.J. Chen, and R.L. Kodell Multiple-testing strategy for analyzing cDNA array data on gene expression Biometrics 60 2004 774 782
20. D. Ecobichon, J.E. Davies, J. Doull, M. Ehrich, R. Joy, D. McMillan, R. Macphail, L.W. Reiter, W. Slikker Jr., and H. Tilson The effect of pesticides on human health S. Baker C. Wilkinson Adv. Mod. Environ. Toxicol. vol. XVIII 1990 Princeton Univ. Press Princeton 131 199
21. A.J. Eisch, and J.F. Marshall Methamphetamine neurotoxicity: dissociation of striatal dopamine terminal damage from parietal cortical cell body injury Synapse 30 1998 433 445
22. T. Ernst, L. Chang, M. Leonido-Yee, and O. Speck Evidence for long-term neurotoxicity associated with methamphetamine abuse Neurology 54 2000 1344 1349
23. G.S. Firestein, and D.S. Pisetsky DNA microarrays: boundless technology or bound by technology? Guidelines for studies using microarray technology Arthritis Rheum. 46 4 2002 859 861
24. D.W. Gaylor, and W. Slikker Jr. Risk assessment for neurotoxic effects Neurotoxicology 11 1990 211 218
25. G. Ginsberg, W. Slikker Jr., J. Bruckner, and B. Sonawane Incorporating children's toxicokinetics into a risk framework alters how chemicals are processed and cleared Environ. Health Perspect. 112 2003 272 283
26. J.G. Hardman, A.G. Gilman, and L.E. Limbird Goodman and Gilman's the Pharmacological Basis of Therapeutics 9th ed. 1996 McGraw-Hill New York 219 221
27. A.J. Hotchkiss, and J.W. Gibb Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain J. Pharmacol. Exp. Ther. 214 1980 257 262
28. R.L. Jakab, and J.F. Bowyer Parvalbumin neuron circuits and microglia in three dopamine-poor cortical regions remain sensitive to amphetamine exposure in the absence of hyperthermia, seizure and stroke Brain Res. 958 2002 52 69
29. F.J. Kogan, W.K. Nichols, and J.W. Gibb Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels Eur. J. Pharm. 36 1976 363 371
30. J. Kopp, A. Nanobashvili, Z. Kokaia, O. Lindvall, and T. Hokfelt Differential regulation of mRNAs for neuropeptide Y and its receptor subtypes in widespread areas of the rat limbic system during kindling epileptogenesis Brain Res. Mol. Brain Res. 72 1999 17 29
31. 14C-trimethyltin in the pregnant rat and fetus Neurotoxicol. Teratol. 11 1989 185 191
32. 11C]WIN-35,428 J. Neurosci. 18 1998 8417 8422
33. M.G. Paule, K. Reuhl, J.J. Chen, S.F. Ali, and W. Slikker Jr. Developmental toxicology of trimethyltin in the rat J. Toxicol. Appl. Pharmacol. 84 2 1986 412 417
34. M.G. Paule, J.M. Cranmer, J.D. Wilkins, H.P. Stern, and E.L. Hoffman Quantitation of complex brain function in children: preliminary evaluation using a nonhuman primate behavioral test battery Neurotoxicology 9 3 1988 367 378
35. M.G. Paule, G.E. Schulze, and W. Slikker Jr. Complex brain function in monkeys as a baseline for studying the effects of exogenous compounds Neurotoxicology 9 1988 463 470
36. D.T. Pearson, and K.N. Dietrich The behavioral toxicology and teratology of childhood: models, methods and implications for intervention Neurotoxicology 6 3 1985 165 182
37. I.T. Salli, N.M. Mazure, J. Sugawara, G. Carland, G.H. Faessen, L. Suen, J.C. Irwin, D.R. Powell, A.J. Giaccia, and L.C. Giudice Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia Proc. Natl. Acad. Sci. U.S.A. 95 1998 10188 10193
38. C.J. Schmidt, J.K. Ritter, P.K. Sonsalla, G.R. Hanson, and J.W. Gibb Role of dopamine in the neurotoxic effects of methamphetamine J. Pharmacol. Exp. Ther. 233 1985 539 544
39. L.C. Schmued, and J.F. Bowyer Methamphetamine exposure can produce neuronal degeneration in mouse hippocampal remnants Brain Res. 759 1997 135 140
40. L.S. Seiden, M.W. Fischman, and C.R. Schuster Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys Drug Alcohol Depend. 1 1975/1976 215 219
41. L.S. Seiden, D.L. Commins, G. Vosmer, K. Axt, and G. Marek Neurotoxicity in dopamine and 5-hydroxytryptamine terminal fields: a regional analysis in nigrostriatal and mesolimbic projections P.W. Kalivas C.B. Nemeroff The Mesocorticolimbic Dopamine System 1988 New York Academy of Sciences New York 161 172
42. D. Sheehan, J.F. Young, W. Slikker Jr., D. Gaylor, and D. Mattison Workshop on risk assessment in reproductive and developmental toxicology: addressing the assumptions and identifying the research needs Regul. Toxicol. Pharmacol. 10 1989 110 122
43. E.K. Silbergeld Maternally mediated exposure of the fetus: in utero exposure to lead and other toxins Neurotoxicology 7 1986 557 568
44. W. Slikker Jr. Biomarkers of neurotoxicity: an overview Biomed. Environ. Sci. 4 1991 192 196
45. W. Slikker Jr., and L. Chang Handbook of Developmental Neurotoxicology 1998 Academic Press 727 732
46. W. Slikker Jr., and D.W. Gaylor Quantitative models of risk assessment for developmental neurotoxicants Handbook of Developmental Neurotoxicology 1998 Academic Press 727 732
47. W. Slikker Jr., and T.J. Sobotka Current and future approaches to neurotoxicity risk assessment Neuroprotective Agents, Annals vol. 825 1997 New York Academy Science 406 418
48. W. Slikker Jr., and T.J. Sobotka Neurotoxicology: molecular biomarkers, transgenics, and imaging technologies H. Salem S.A. Katz Alternative Toxicological Methods 2003 CRC Press 329 332
49. W. Slikker, A. Scallet, and D.W. Gaylor Biologically-based dose-response model for neurotoxicity risk assessment Toxicol. Lett. 102-103 1998 429 433
50. W. Slikker Jr., B.D. Beck, D.A. Cory-Slechta, M.G. Paule, W.K. Anger, and D. Bellinger Cognitive tests: interpretation for neurotoxicity? (Workshop Summary) Toxicol. Sci. 58 2000 222 234
51. I. Torres-Aleman, S. Pons, and M.A. Arevalop The insulin-like growth factor I system in the rat cerebellum: developmental regulation and role in neuronal survival and differentiation J. Neurosci. Res. 39 2 1994 117 126
52. U.S. EPA (Environmental Protection Agency), 1986. Air Quality Criteria for Lead, vols. I-IV (Document No. EPA-600/8/028aF). Research Triangle Park, NC.
53. N.D. Volkow, L. Chang, G.J. Wang, J.S. Fowler, M. Leonido-Yee, D. Franceschi, M.J. Sedler, S.J. Gatley, R. Hitzemann, Y.S. Ding, J. Logan, C. Wong, and E.N. Miller Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers Am. J. Psychiatry 158 2001 377 382
54. N.D. Volkow, L. Chang, G.J. Wang, J.S. Fowler, M. Leonido-Yee, D. Franceschi, M.J. Sedler, S.J. Gatley, R. Hitzemann, Y.S. Ding, C. Wong, and J. Logan Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers Am. J. Psychiatry 158 2001 383 389
55. B. Weiss Risk assessment: the insidious nature of neurotoxicity and the aging brain Neurotoxicology 11 1990 305 323
56. T. Xie, L. Tong, T. Barrett, J. Yuan, G. Hatzidimitriou, U.D. McCann, K.G. Becker, D.M. Donovan, and G.A. Ricaurte Changes in gene expression linked to methamphetamine-induced dopaminergic neurotoxicity J. Neurosci. 22 2002 274 283